Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy

The Journal of Infectious Diseases
K D YangH R Hill

Abstract

To study the mechanism of bacterial opsonization by immune globulin intravenous (IGIV) complement consumption and polymorphonuclear leukocyte (PMNL) membrane receptor (FcRlo, CR1, and CR3)-mediated phagocytosis of Staphylococcus epidermidis, Klebsiella pneumoniae, and groups A and B streptococci were examined. IGIV alone did not consume complement and showed no opsonic activity by itself for these organisms. When these bacteria were preopsonized in IGIV, significant amounts of complement were consumed (44%-94%) and the uptake and killing of bacteria occurred. The in vitro opsonic activity of IGIV for these organisms was significantly correlated with the amount of complement consumed by the IGIV-opsonized bacteria (r = .85, P less than .05). The in vivo protective efficacy of IGIV also appeared to be directly associated with its ability to activate and consume complement (r = 1.0, P less than .001). Antibodies to FcRlo (Leu 11) markedly inhibited phagocytosis of bacteria opsonized in IGIV but not that of bacteria opsonized in specific IgM. Both CR1 and CR3 receptors on PMNLs were involved in uptake, but the contribution of each is different with different organisms.

Citations

Aug 10, 2000·British Journal of Haematology·R Carr
May 23, 2006·Infection and Immunity·Philipp Henneke, Reinhard Berner
Oct 8, 2008·Immunological Reviews·Julia Wennekamp, Philipp Henneke
Jan 1, 1992·Clinical Immunology and Immunopathology·H R HillH V Raff
Apr 21, 2006·Archives of Medical Research·Antonio ArboJosé Ignacio Santos
Nov 19, 2003·Scandinavian Journal of Infectious Diseases·Anna Norrby-TeglundJessica Darenberg
Aug 1, 1991·Infection and Immunity·G E SchutzeM S Edwards
Jun 1, 1994·Infection and Immunity·A G CorreaM S Edwards

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.